Clinical Pharmacology of Mezlocillin
Mezlocillin is a new broad-spectrum semisynthetic penicillin that has shown encouraging in vitro activity against the infecting organisms most likely to cause mortality and morbidity in cancer patients receiving chemotherapy. The serum clearances and urine recoveries of mezlocillin, ampicillin, and...
Guardat en:
| Publicat a: | Antimicrob Agents Chemother |
|---|---|
| Autors principals: | , , |
| Format: | Artigo |
| Idioma: | Inglês |
| Publicat: |
American Society for Microbiology (ASM)
1978
|
| Matèries: | |
| Accés en línia: | https://ncbi.nlm.nih.govhttps://pmc.ncbi.nlm.nih.gov/articles/PMC352210/ https://ncbi.nlm.nih.govhttps://pubmed.ncbi.nlm.nih.gov/646340/ https://ncbi.nlm.nih.govhttps://doi.org/10.1128/aac.13.2.180 |
| Etiquetes: |
Sense etiquetes, Sigues el primer a etiquetar aquest registre!
|